The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nacsys 600 mg Effervescent Tablets

Alpex Pharma (Irl) LimitedPA2166/001/001

Main Information

Trade NameNacsys 600 mg Effervescent Tablets
Active SubstancesAcetylcysteine
Dosage FormEffervescent tablet
Licence HolderAlpex Pharma (Irl) Limited
Licence NumberPA2166/001/001

Group Information

ATC CodeR05CB Mucolytics
R05CB01 acetylcysteine


License statusAuthorised
Licence Issued02/06/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back